NCT06331559 2026-02-09
Study of SIM0501 Alone and in Combination in Patients With Advanced Solid Tumors
Jiangsu Simcere Pharmaceutical Co., Ltd.
Phase 1 Terminated
Clinical Trials
34 trialsNCT05868915 2026-01-21
HV-101 for Patients With Advanced Solid Tumors
Hervor Therapeutics
Phase 1 Terminated
NCT03968653 2025-12-05
Study of Oral Debio 0123 in Combination With Carboplatin in Participants With Advanced Solid Tumors
Debiopharm International SA
Phase 1 Terminated
NCT03522142 2025-10-09
A Study Exploring the Safety and Tolerability of INCB081776 in Participants With Advanced Malignancies
Incyte Corporation
Phase 1 Terminated
NCT03034304 2025-07-24
A Phase I Clinical Study for Evaluating the Safety and Efficacy of MASCT-I in Patients With Advanced Solid Tumors
HRYZ Biotech Co.
Phase 1 Terminated
NCT04074759 2025-01-23
FPT155-001
Five Prime Therapeutics, Inc.
Phase 1 Terminated
NCT03854227 2025-01-13
A Dose Escalation Study Of PF-06939999 In Participants With Advanced Or Metastatic Solid Tumors
Pfizer
Phase 1 Terminated
NCT03387917 2024-12-02
TLD-1, a Novel Liposomal Doxorubicin, in Patients With Advanced Solid Tumors
Swiss Cancer Institute
Phase 1 Terminated
NCT02994953 2024-09-20
COMBO
EMD Serono
Phase 1 Terminated
NCT04747470 2024-09-03
Study to Assess the Effects of GS-3583 in Participants With Advanced Solid Tumors
Gilead Sciences
Phase 1 Terminated
NCT03954704 2023-11-21
Study of Dalutrafusp Alfa (Formerly GS-1423) in Participants With Advanced Solid Tumors
Gilead Sciences
Phase 1 Terminated
NCT05470933 2023-09-01
A Study Explore WJ01075 Tablets in Patients With Advanced Solid Tumors
Suzhou Junjing BioSciences Co., Ltd.
Phase 1 Terminated
NCT04601285 2023-07-06
A Phase I Study of JS108 in Patients With Advanced Solid Tumors
Shanghai Junshi Bioscience Co., Ltd.
Phase 1 Terminated
NCT04746612 2023-03-30
First in Human Study to Evaluate the Safety, Tolerability of HH30134 in Advanced Solid Tumors
Haihe Biopharma Co., Ltd.
Phase 1 Terminated
NCT04735796 2022-10-26
Study of LM-102 in Subjects in Advanced Tumors
LaNova Medicines Limited
Phase 1 Terminated
NCT04049617 2022-10-06
Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Efficacy of Evixapodlin (Formerly GS-4224) in Participants With Advanced Solid Tumors
Gilead Sciences
Phase 1 Terminated
NCT05008913 2022-09-06
ADME
AstraZeneca
Phase 1 Terminated
NCT03665129 2022-01-27
STELLAR-001
Innate Pharma
Phase 1 Terminated
NCT01529307 2020-12-21
First in Human Trial of TAS266 in Patients With Advanced Solid Tumors
Novartis
Phase 1 Terminated
NCT01064089 2020-12-08
Dose Escalation of HSP990 in Japan/Korea
Novartis
Phase 1 Terminated
NCT03256331 2020-06-01
Evaluate the Safety of BEL-X-HG in Advanced Cancer Patients
Belx Bio-Pharmaceutical (Taiwan) Corporation
Phase 1 Terminated
NCT03700294 2020-05-01
Safety, Tolerability, Pharmacokinetics, and Antitumor Study of ADCT-601 to Treat Advanced Solid Tumors
ADC Therapeutics S.A.
Phase 1 Terminated
NCT01163071 2019-11-14
A Phase 1 Trial of ABI-011 in Patients With Advanced Solid Tumors or Lymphomas
Celgene
Phase 1 Terminated
NCT03320525 2018-10-02
CHITIN
Herlev Hospital
Phase 1 Terminated
NCT02243917 2018-02-27
A Phase 1 Study Evaluating CB-5083 in Subjects With Advanced Solid Tumors
Cleave Biosciences, Inc.
Phase 1 Terminated
NCT02040558 2017-04-05
Trial to Study the Safety of Intravenous MNK-010 in Advanced Solid Tumors
Mallinckrodt
Phase 1 Terminated
NCT00359671 2016-11-29
Treatment With MK6592 and an Anti-cancer Drug in Patients With Advanced Solid Tumors (6592-001)
Merck Sharp & Dohme LLC
Phase 1 Terminated
NCT00632424 2016-03-10
Phase 1 Trial of Oral Ixabepilone
R-Pharm
Phase 1 Terminated
NCT01497626 2016-02-17
Lapatinib and Bortezomib in Patients With Advanced Malignancies
Georgetown University
Phase 1 Terminated
NCT01004822 2015-11-20
A Safety, Tolerability, And Pharmacokinetic Trial With CVX-241 In Patients With Advanced Solid Tumors
Pfizer
Phase 1 Terminated
NCT00932126 2015-10-28
This Is The First Study Using Escalating Doses Of PF-03758309, An Oral Compound, In Patients With Advanced Solid Tumors
Pfizer
Phase 1 Terminated
NCT00951158 2015-05-12
A Molecular Pharmacodynamic Dose-titration Trial of Conjugated Linoleic Acid (CLA; Clarinol®) in Patients With Advanced Solid Tumors
Dartmouth-Hitchcock Medical Center
Phase 1 Terminated
NCT01286974 2012-09-21
A Pharmacokinetic Study to Access How the Body Absorbs and Removes Linifanib in Male Patients With Advanced Solid Tumors.
Abbott
Phase 1 Terminated
NCT01016327 2012-09-07
Study of NMS-1116354 in Solid Tumors
Nerviano Medical Sciences
Phase 1 Terminated